Physicochemical Properties
| Molecular Formula | C20H34O |
| Molecular Weight | 290.48336 |
| Exact Mass | 290.261 |
| CAS # | 13487-46-2 |
| PubChem CID | 10891603 |
| Appearance | Typically exists as solid at room temperature |
| LogP | 6.124 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 14 |
| Heavy Atom Count | 21 |
| Complexity | 297 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | OCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC |
| InChi Key | NYBCZSBDKXGAGM-DOFZRALJSA-N |
| InChi Code | InChI=1S/C20H34O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21/h6-7,9-10,12-13,15-16,21H,2-5,8,11,14,17-20H2,1H3/b7-6-,10-9-,13-12-,16-15- |
| Chemical Name | (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraen-1-ol |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Wax esters are created when arachidonic alcohol, which can be produced from arachidonic acid, builds up inside of cells. An novel kind of Acinetobacter sp. Arachidonic acid can be effectively converted to arachidonic acid by N-476-2 [1]. |
| References | [1]. Toshihiro Nagao, et al. Microbial Conversion of Arachidonic Acid to Arachidonyl Alcohol by a New Acinetobacter Species. Journal of the American Oil Chemists' Society volume 89, pages1663–1671(2012) |
| Additional Infomation | (5Z,8Z,11Z,14Z)-icosatetraen-1-ol is a long-chain primary fatty alcohol that is (5Z,8Z,11Z,14Z)-icosatetraene in which one of the methyl hydrogens at position 1 is replaced by a hydroxy group. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~100 mg/mL (~344.26 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (7.16 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (7.16 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (7.16 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.4426 mL | 17.2129 mL | 34.4258 mL | |
| 5 mM | 0.6885 mL | 3.4426 mL | 6.8852 mL | |
| 10 mM | 0.3443 mL | 1.7213 mL | 3.4426 mL |